IMUX
Closed
Immunic Inc
0.6904
-0.0071 (-1.02%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 0.6975
Day's Range: 0.6896 - 0.74
Send
sign up or login to leave a comment!
When Written:
1.59
Immunic Inc is a clinical-stage biopharmaceutical company that focuses on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The company's lead product candidate, IMU-838, is a selective immune modulator that targets the intracellular metabolism of activated immune cells. It is currently being evaluated in clinical trials for the treatment of multiple sclerosis, ulcerative colitis, and COVID-19. Immunic also has a pipeline of other drug candidates in development for various indications, including inflammatory bowel disease, psoriasis, and lupus. The company was founded in 2016 and is headquartered in New York City.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








